Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic

Sexually Transmitted Infections

Volumn 89, Issue 6, 2013, Pages 514-518

  Muzny, Christina A ^a   Rivers, Charles A ^a   Austin, Erika L ^a   Schwebke, Jane R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DRUG ABUSE; ELECTRONIC MEDICAL RECORD; FEMALE; GYNECOLOGIC CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT COUNSELING; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REPRODUCTIVE HISTORY; RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE; TOBACCO DEPENDENCE; TRICHOMONIASIS; UNITED STATES; UNIVERSITY HOSPITAL; VIRUS LOAD; VIRUS TRANSMISSION;

CLINICAL STI CARE; HIV WOMEN; TRICHOMONAS;

ADULT; AGED; ALABAMA; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PREVALENCE; SEXUAL BEHAVIOR; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; VIRAL LOAD; YOUNG ADULT;

EID: 84884530700     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050889     Document Type: Article

References (29)

1. WHO Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections.2001.
2. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-Age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-26.
3. Shuter J, Bell D, Graham D, et al. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis 1998;25:303-7. (Pubitemid 28309068)
4. Cu-Uvin S, Ko H, Jamieson DJ, et al. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis 2002;34:1406-11. (Pubitemid 34507952)
5. Wendel KA, Erbelding EJ, Gaydos CA, et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002;35:576-80.
6. Zhang ZF. Epidemiology of trichomonas vaginalis. A prospective study in China. Sex Transm Dis 1996;23:415-24.
7. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001;7:927-32.
8. Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis 2004;31:547-51. (Pubitemid 39122137)
9. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007;195:698-702.
10. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008;197:548-54. (Pubitemid 351321532)
11. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998;177:167-74. (Pubitemid 28030448)
12. Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 1998;351:213-14. (Pubitemid 28037021)
13. Anderson BL, Firnhaber C, Liu T, et al. Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis 2012;39:638-42.
14. Sorvillo F, Kovacs A, Kerndt P, et al. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg 1998;58:495-500. (Pubitemid 28183263)
15. Kissinger PJ, Dumestre J, Clark RA, et al. Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis 2005;32:227-30. (Pubitemid 40411578)
16. Seth P, Wingood GM, Diclemente RJ. Exposure to alcohol problems and its association with sexual behaviour and biologically confirmed Trichomonas vaginalis among women living with HIV. Sex Transm Infect 2008;84:390-2.
17. Clark RA, Theall KP, Amedee AM, et al. Frequent douching and clinical outcomes among HIV-infected women. Sex Transm Dis 2007;34:985-90. (Pubitemid 350158849)
18. Monteiro CA, Bachmann LH, Desmond RA, et al. Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic. AIDS Res Hum Retroviruses 2004;20:577-83. (Pubitemid 38813653)
19. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003;52(RR-12):1-24.
20. Liu CM, Muirhead KA, George SP, et al. Flow cytometric monitoring of human immunodeficiency virus-infected patients. Simultaneous enumeration of five lymphocyte subsets. Am J Clin Pathol 1989;92:721-8. (Pubitemid 20007634)
21. Niccolai LM, Kopicko JJ, Kassie A, et al. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis 2000;27:284-8. (Pubitemid 30252421)
22. Magnus M, Clark R, Myers L, et al. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis 2003;30:839-43. (Pubitemid 37386215)
23. Marrone J, Fairley CK, Saville M, et al. Temporal associations with declining Trichomonas vaginalis diagnosis rates among women in the state of Victoria, Australia, 1947 to 2005. Sex Transm Dis 2008;35:572-6.
24. Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012;50:2601-8.
25. Gaydos CA, Hsieh YH, Barnes M, et al. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex Transm Dis 2011;38:828-32.
26. CDC. Sexually transmitted disease surveillance, 2008. Atlanta, GA: US Department of Health and Human Services, CDC, 2009
27. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 2009;200:188 e1-7.
28. Schwebke JR, Hobbs MM, Taylor SN, et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol 2011;49:4106-11.
29. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59(RR-12):1-110.